No 01 2024

The Board of Directors of Flerie and the Board of Directors of Biosergen have adopted a plan to join forces through a statutory merger between the companies in accordance with the Swedish Companies Act.

Veeva Systems has acquired Copli, focusing on agentic medical, legal, and regulatory (MLR) solutions for the life sciences industry.

Merck and Bio-Techne Corporation have entered into a definitive agreement pursuant to which Merck will, subject to customary closing conditions, acquire Bio-Techne for USD 73 per share in cash, representing a total enterprise value of approximately USD 11.3 billion, a 36% premium to Bio-Techne’s one-month volume weighted average trading price.

The agreement, building on a letter of intent announced earlier this year, is intended to establish a long-term partnership in spray-dried formulations, a technology considered important for the development of inhalable drug formulations for biologics, vaccines, and other large molecules.

A newly approved EUR 2.8 million project will, over the next three years, bring together leading organizations from Sweden, Denmark and Norway to accelerate commercialization, investment and market access for companies developing solutions in women's health.

Following the outcome of the DIAGNODE-3 study, the company’s immediate priority is to complete the close-out of the Phase 3 program in an efficient and responsible manner, it states.

The partnership will leverage Combotope’s SMART-Phage platform to generate highly tumor-selective antibodies for next-generation cancer therapies.